Anticoagulation Management in Sepsis-Associated Troponin Elevation

Understanding the Risks of Additional Anticoagulation

Adding aspirin to oral anticoagulation doubles bleeding risk without providing additional stroke protection, as aspirin provides inferior stroke prevention compared to oral anticoagulation in atrial fibrillation, according to the American Heart Association 1
The combination of oral anticoagulation with aspirin provides no additional stroke benefit but doubles bleeding risk, as stated by the American College of Cardiology 1
Elderly patients (≥75 years) already have approximately twice the risk of serious bleeding during anticoagulation compared to younger patients, as reported by the American Stroke Association 3

The European Society of Cardiology recommends continuing Eliquis (apixaban) monotherapy for atrial fibrillation stroke prevention, as it reduces stroke risk by 64-68% compared to aspirin or no treatment 2
The American Heart Association suggests optimizing modifiable bleeding risk factors during sepsis, including aggressively controlling blood pressure (target <140/90 mmHg, ideally <130/80 mmHg) and avoiding NSAIDs completely 1
The European Society of Cardiology advises calculating creatinine clearance using Cockcroft-Gault formula to ensure appropriate Eliquis dosing, and reviewing all concomitant medications for drug interactions 1

The American College of Cardiology warns that concomitant administration of an oral anticoagulant with additional anticoagulant agents dramatically increases bleeding risk, and that anticoagulation-related complications occurred significantly more often in anticoagulated groups 1
The European Society of Cardiology recommends verifying appropriate Eliquis dosing, with a standard dose of 5 mg twice daily, and reducing to 2.5 mg twice daily if ≥2 of: age ≥80 years, weight ≤60 kg, serum creatinine ≥1.5 mg/dL 2